Clinical methods of investigating endothelial function;Les méthodes cliniques d'exploration de la fonction endothéliale

Sang Thrombose Vaisseaux

Volumn 15, Issue 7, 2003, Pages 387-396

  Joannidès, Robinson ^a   Bellien, Jérémy ^a  

^a INSERM   (France)

Author keywords

Acetylcholine; Endothelium; Flow dependent dilatation; Pharmacology; Prognosis

Indexed keywords

ACETYLCHOLINE; ACTIVATED PROTEIN C; ARGININE DERIVATIVE; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; NITRIC OXIDE DONOR; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE AGENT; VON WILLEBRAND FACTOR;

ACCURACY; ANGIOGRAPHY; B SCAN; BLOOD FLOW; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; COLD PRESSOR TEST; CORONARY ARTERY; CORONARY BLOOD VESSEL; DOPPLER FLOWMETRY; ECHOTRACKING; ENDOTHELIAL DYSFUNCTION; FLOW DEPENDENT VASODILATATION; FUNCTION TEST; FUNCTIONAL ASSESSMENT; HAND SKIN HEATING; HEATING; HIGH RISK PATIENT; HUMAN; HYPEREMIA; MUSCLE BLOOD VESSEL; NONHUMAN; PERIPHERAL CIRCULATION; PHARMACOLOGY; PLETHYSMOGRAPHY; POSTISCHEMIC HYPEREMIA; PROGNOSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE ANGIOGRAPHY; RESISTANCE BLOOD VESSEL; SHORT SURVEY; SKIN BLOOD VESSEL; ULTRASOUND; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0346119163     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-6.
2. Kelm M, Preik-Steinhoff H, Preik M, Strauer BE. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginin-NO pathway. Cardiovasc Res 1999; 41: 765-72.
3. Lerman A, Holmes DR, Bell MR, Garrat KN, Nishimura RA, Burnett JC. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-31.
4. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-25.
5. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-6.
6. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96: 3042-7.
7. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993; 88: 2030-4.
8. Jansson JH, Nilsson TK, Johnson O. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-5.
9. Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 1998; 98: 1842-7.
10. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3.
11. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the response to drugs and mediators. Hypertension 1995; 25: 918-23.
12. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
13. Johnson JM, Taylor WF, Sheperd AP, Park MK. Laser-Doppler measurement of skin blood flow: comparison with plethysmography. J Appl Physiol 1984; 56: 798-803.
14. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins. Br J Clin Pharmacol 1994; 38: 181-96.
15. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
16. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989; 80: 466-74.
17. Wilkinson IB, Hall IR, McCallum H, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-52.
18. Girerd X, Boutouyrie P, Pannier B, Mourad JJ, Safar M, Laurent S. Noninvasive ultrasound methods for the measurement of arterial wall thickness. In intima-media thickness and atherosclerosis: Predicting the risck? In: Touboul PJ, ed. Londres: Parthenon, 1996: 45-58.
19. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effect of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993; 92: 652-62.
20. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989; 79: 93-100.
21. Laurent S, Lacolley P, Brunnel P, Laloux B, Pannier B. Safar M. Flow-dependent vasodilatation of brachial artery in essential hypertension. Am J Physiol 1990; 258: H1004-11.
22. Joannidès R, Haefeli W, Linder L, et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-9.
23. Joannidès R, Bakkali ELH, Richard V, Moore N, Thuillez C. Evaluation of the determinants of flow-mediated radial artery vasodilatation in humans. Clin Exper Hypertens 1997; 12: 813-26.
24. Doshi SN, Naka KK, Payne N, et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 2001; 101: 629-35.
25. Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111-8.
26. Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol 2000; 50: 397-404.
27. Bresler B, Chan S, Mancini GBJ. Temporal response of brachial artery dilatation after occlusion and nitroglycerin. Am J Cardiol Ccirdiol 2000; 85: 396-400.
28. Joannides R, Costentin A, Iacob M, Bakkali el-H, Richard MO, Thuillez C. Role of arterial smooth muscle tone and geometry in the regulation of peripheral conduit artery mechanics by shear stress. Clin Exp Pharmacol Physiol 2001; 28: 1025-31.
29. Joannides R, Costentin A, Iacob M, Compagnon P, Lahary A, Thuillez C. Influence of vascular dimension on gender difference in flow-dependent dilatation of peripheral conduit arteries. Am J Physiol Heart Circ Physiol 2002; 282: H1262-9.
30. Joannides R, Bizet-Nafeh C, Costentin A, et al. Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure. Hypertension 2001; 38: 1446-50.